Serzone and Gingivitis - a phase IV clinical study of FDA data

Summary:

Gingivitis is reported as a side effect among people who take Serzone (nefazodone hydrochloride), especially for people who are male, 60+ old, also take Xanax, and have Bone density abnormal.

The phase IV clinical study analyzes which people have Gingivitis when taking Serzone. It is created by eHealthMe based on reports of 7,594 people who have side effects when taking Serzone from the FDA, and is updated regularly.

What is Serzone?

Serzone has active ingredients of nefazodone hydrochloride. It is often used in depression. eHealthMe is studying from 7,695 Serzone users. Check the latest studies of Serzone.

What is Gingivitis?

Gingivitis (inflammation of gums) is found to be associated with 887 drugs and 803 conditions by eHealthMe. Check the latest studies of Gingivitis.

On Jul, 10, 2026

7,594 people reported to have side effects when taking Serzone.
Among them, 17 people (0.22%) have Gingivitis.

Among these 17 people:

What is the gender of people who have Gingivitis when taking Serzone? *

female: 17.65 %
male: 82.35 %

What is the age of people who have Gingivitis when taking Serzone? *

What are other drugs people take besides Serzone? *

What are other side effects people have besides Gingivitis? *

Chest Pain: 15 people, 88.24%
Spinal Osteoarthritis (joint cartilage loss in spine): 14 people, 82.35%
Intervertebral Disc Degeneration (spinal disc degeneration): 14 people, 82.35%
Haemoglobin Decreased: 14 people, 82.35%
Fatigue (feeling of tiredness): 14 people, 82.35%
Hypoaesthesia (reduced sense of touch or sensation): 14 people, 82.35%
Pain In Extremity: 14 people, 82.35%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 82.35%
Renal Cyst (kidney cyst): 14 people, 82.35%
Joint Pain: 14 people, 82.35%

What are the existing conditions these people have? *

Prostate Cancer: 13 people, 76.47%
Pain: 13 people, 76.47%
Bone Density Abnormal: 13 people, 76.47%
Sleep Disorder: 1 person, 5.88%
Sedation: 1 person, 5.88%
Psychotic Disorder: 1 person, 5.88%
Neuropathy Peripheral (surface nerve damage): 1 person, 5.88%
Muscle Aches (muscle pain): 1 person, 5.88%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%
Libido Decreased (loss of interest in sex): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Serzone and have Gingivitis?

- Check whether Gingivitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serzone:

Serzone (7,695 reports)

Gingivitis treatments and more:

Gingivitis (9,610 reports)

Browse all side effects of Serzone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingivitis:

Gingivitis (887 drugs)

Browse all the conditions that are associated with Gingivitis:

Gingivitis (803 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on nefazodone hydrochloride (the active ingredients of Serzone) and Serzone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.